Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook-Reference-Cited by-同舟云学术

Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook

Published:2018-01-10 Issue:5-6 Volume:26 Page:435-447
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Mu Qingxin¹,Yu Jesse¹,McConnachie Lisa A.¹,Kraft John C.¹,Gao Yu¹²,Gulati Gaurav K.¹,Ho Rodney J. Y.¹³

Affiliation:

1. Department of Pharmaceutics, University of Washington, Seattle, WA, USA;

2. Cancer Metastasis Alert and Prevention Center, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou, China;

3. Department of Bioengineering, University of Washington, Seattle, WA, USA

Funder

NIH

Natural Science Foundation of China

Natural Science Foundation of Fujian Province

China Scholarship Council

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2017.1419363

Reference102 articles.

1. Drug Products

2. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs

3. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

4. Intestinal Permeation Enhancers

5. Nanoparticle-based targeted drug delivery

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Editor's challenge: Dr. Qingxin Mu - how can nanomedicine approaches advance multi-targeting strategy in combination cancer therapy?;Frontiers in Oncology;2024-06-11

2. Permanently Charged Cationic Lipids—Evolution from Excipients to Therapeutic Lipids;Small Science;2024-06-11

3. Injectable long-acting formulations (ILAFs) and manufacturing techniques;Expert Opinion on Drug Delivery;2024-06-02

4. Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products;Genes;2024-04-08

5. Clinical translation of gold nanoparticles: obstacles and perspectives;Gold Nanoparticles for Drug Delivery;2024